CE
ABBV icon

Cornerstone Enterprises’s AbbVie ABBV Stock Holding History

Cornerstone Enterprises’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,621
Closed -$3.08M – 30
2024
Q3 		$3.08M Buy
15,621
+390
+3% +$72.8K 1.93% 15
2024
Q2 		$2.61M Buy
15,231
+396
+3% +$65.6K 1.73% 17
2024
Q1 		$2.68M Buy
14,835
+1,467
+11% +$253K 1.97% 15
2023
Q4 		$2.07M Buy
+13,368
New +$1.95M 1.85% 14

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cornerstone Enterprises's ABBV Position: Q4 2024 in Review

Cornerstone Enterprises sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 15,621 shares — an estimated $3.08M sold.

Cornerstone Enterprises first reported a position in ABBV in Q4 2023 and held it in 4 quarters. The position peaked at $3.08M in Q3 2024. 3,749 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Cornerstone Enterprises reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Cornerstone Enterprises sold 15,621 AbbVie shares in Q4 2024, an estimated $3.08M.
  • Cornerstone Enterprises first reported a position in AbbVie in Q4 2023 and held it in 4 quarters.
  • Cornerstone Enterprises's AbbVie position peaked at $3.08M in Q3 2024.
  • 3,749 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Cornerstone Enterprises's 13F filing for Q4 2024, filed 13 Feb 2025.